| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.862 | 7.981 | 12.452 | 14.349 | 12.081 | 9.820 | 9.208 | 9.074 | 8.976 | 9.724 |
| Total Income - EUR | 6.862 | 7.981 | 12.455 | 14.349 | 12.081 | 9.820 | 9.208 | 9.074 | 8.976 | 9.724 |
| Total Expenses - EUR | 6.280 | 7.203 | 11.038 | 13.752 | 10.882 | 7.163 | 6.058 | 5.174 | 5.818 | 5.402 |
| Gross Profit/Loss - EUR | 582 | 777 | 1.417 | 597 | 1.199 | 2.657 | 3.150 | 3.900 | 3.158 | 4.322 |
| Net Profit/Loss - EUR | 375 | 618 | 1.292 | 453 | 1.078 | 2.385 | 2.906 | 3.833 | 2.728 | 3.644 |
| Employees | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Emiroral S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 935 | 3.028 | 1.733 | 1.497 | 2.124 | 4.513 | 7.285 | 5.091 | 7.539 | 7.044 |
| Inventories | 925 | 1.516 | 1.729 | 1.337 | 1.406 | 2.273 | 2.023 | 2.167 | 946 | 2.168 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 9 | 1.512 | 4 | 159 | 719 | 2.240 | 5.262 | 2.923 | 6.593 | 4.876 |
| Shareholders Funds | -1.338 | -707 | 598 | 1.040 | 2.098 | 4.443 | 7.251 | 4.703 | 7.418 | 3.693 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.273 | 3.735 | 1.135 | 456 | 26 | 70 | 33 | 387 | 122 | 3.351 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3109 - 3109" | |||||||||
| CAEN Financial Year |
3109
|
|||||||||
Comments - Emiroral S.r.l.